MERECA Survival Plots – English
The graphs included below provide details on the survival status of all patients in each study arm (56 in the ilixadencel Treatment Groups and 30 in the Control Group), as of the last follow-up in July 2019. Patients will continue to be followed on a six-month basis.
Deprecated: Theme without comments.php is deprecated since version 3.0.0 with no alternative available. Please include a comments.php template in your theme. in /home/i/immunicu/www/wp-includes/functions.php on line 4977